Prevalence of Hepatitis B Core Antibodies and Occult Hepatitis B Infection among Blood Donors in Erbil Governorate, Iraq
DOI:
https://doi.org/10.21928/uhdjst.v9n2y2025.pp1-6Keywords:
Blood Donors, Hepatitis B Core Antibody, Occult Hepatitis B, Quantitative Polymerase Chain Reaction, ErbilAbstract
The Hepatitis B Virus (HBV) remains a considerable risk to blood transfusion safety, especially through occult hepatitis B infection (OBI), defined by undetectable Hepatitis B surface antigen (HBsAg) yet the presence of HBV DNA in the bloodstream. Identifying and investigating the prevalence of OBI is essential as these infections can get past normal screening tests, which can lead to accidental transmission through transfusion. This study aimed to evaluate the prevalence of total hepatitis B core antibody (HBcAb) and identify OBI among blood donors in Erbil Governorate, Iraq. A total of 31,631 blood donors were tested for total HBcAb between September 2024 and January 2025, using the Liaison XL chemiluminescence immunoassay machine. Out of these 31,631 blood donors, 388 (1.23%) showed positive results for the total HBcAb. Among the positive cases, 65 samples were randomly chosen to detect OBI by viral load detection using quantitative real-time polymerase chain reaction. All samples were negative for HBsAg during routine screenings. Occult OBI was detected within 17 (26.15%) of the HBcAb-positive, HBsAg-negative blood donors. Despite the application of HBcAb screening, the absence of molecular testing may continue to provide an opportunity for HBV transmission. Incorporating HBV DNA testing for positive cases may enhance the safety of blood transfusions.
References
World Health Organization. “Global Hepatitis Report 2024: Action for Access in Low-and Middle-Income Countries”. World Health Organization, Switzerland, 2024.
World Health Organization. “Global Hepatitis Report 2017”. World Health Organization, Switzerland, Switzerland, 2017.
M. Abebe, B. Alemnew and S. Biset. “Prevalence of hepatitis B virus and hepatitis C virus among blood donors in Nekemte blood bank, Western Oromia, Ethiopia: Retrospective 5 years study”. Journal of Blood Medicine, vol. 11, pp. 543-550, 2020.
R. Raimondo, S. Locarnini, T. Pollicino, M. Levrero, F. Zoulim and A. S. Lok. “Update of the statements on biology and clinical impact of occult hepatitis B virus infection”. Journal of Hepatology, vol. 71, no. 2, pp. 397-408, 2019.
R. Nwalozie, L. S. Danagogo, J. A. Kareem and B. A. Nnokam. “The course of HBcAb as a surrogate marker for occult hepatitis B infection: A population based survey in Rivers State Nigeria”. Journal of Applied Health Sciences and Medicine, vol. 4, no. 10, pp. 7-12, 2024.
D. Fopa, D. Candotti, C. T. Tagny, C. Doux, D. Mbanya, E. L. Murphy, H. I. Kenawy, F. El Chenawi and S. Laperche. “Occult hepatitis B infection among blood donors from Yaoundé, Cameroon”. Blood Transfusion, vol. 17, no. 6, pp. 403-408, 2019.
M. Spreafico, A. Berzuini, B. Foglieni, D. Candotti, L. Raffaele, I. Guarnori, A. Colli, F. F. Maldini, J. P. Allain and D. Prati. “Poor efficacy of nucleic acid testing in identifying occult HBV infection and consequences for safety of blood supply in Italy”. Journal of Hepatology, vol. 63, no. 5, pp. 1068-1076, 2015.
M. X. Fu, A. Elsharkawy, B. Healy, C. Jackson, D. Bradshaw, E. Watkins, I. Ushiro-Lumb, J. Griffithsh, J. Neubergerb, K. Maguirei, M. Desaij, N. McDougallk, N. Priddeel, S. T. Barclaym, S. Blackmoren, P. Simmondsa, W. L. Irvingo and H. Harvala. “Occult hepatitis B virus infection: Risk for a blood supply, but how about individuals’ health?” EClinicalMedicine, vol. 81, p. 103095, 2025.
D. Candotti, S. M. Assennato, S. Laperche, J. P. Allain and S. Levicnik-Stezinar. “Multiple HBV transfusion transmissions from undetected occult infections: Revising the minimal infectious dose”. Gut, vol. 68, no. 2, pp. 313-321, 2019.
J. P. Allain. “Global epidemiology of occult HBV infection”. Annals of Blood, vol. 2, no. 5, p. 7, 2017.
N. R. Hussein. “Risk factors of hepatitis B virus infection among blood donors in Duhok city, Kurdistan Region, Iraq”. Caspian Journal of Internal Medicine, vol. 9, no. 1, pp. 22-26, 2018.
T. K. Alzubiery, T. Alhazari, J. C. Alcantara, S. A. Majed, A. S. Bazaid and A. Aldarhami. “Updated seroprevalence of hepatitis B surface antigen and anti-hepatitis core antibody among blood donors in Yemen”. Infection and Drug Resistance, vol. 15, pp. 2787-2796, 2022.
M. H. O. Ebar, H. A. M. Abdalla and M. A. A. O. Albara. “Prevalence of hepatitis B core antibody in Sudanese random blood donors at Khartoum State”. Journal of Drug Delivery and Therapeutics, vol. 12, no. 6, pp. 44-47, 2022.
Y. AlRashdan, K. Al-Jaff and M. Najdawi. “Occult hepatitis B in blood donation centers”. Journal of Medicine and Life, vol. 16, no. 4, p. 571, 2023.
A. Khanum, A. Alamri, A. Alshehr, A. Alsabrah, M. Alshehri, F. S. Alshehri and G. Albahja. “Identification of occult hepatitis B infection (OBI) among blood donors at “Aseer” Southern Region in Saudi Arabia”. Journal of Blood Disorders and Transfusion, vol. 15, p. 572, 2024.
M. N. Mbencho, N. Hafza, L. C. Cao, V. N. Mingo, E. A. Achidi, S. M. Ghogomu and T. P. Velavan. “Incidence of occult hepatitis B infection (OBI) and hepatitis B genotype characterization among blood donors in Cameroon”. PLoS One, vol. 19, no. 10, p. e0312126, 2024.
S. Boumbaly, T. A. L. Balde, A. V. Semenov, Y. V. Ostankova, E. N. Serikova, E. V. Naidenova, D. E. Valutite, A. N. Shchemelev, E. B. Zueva, E. V. Esaulenko, A. A. Totolian. “Prevalence of viral hepatitis B markers among blood donors in the Republic of Guinea”. Problems of Virology, vol. 67, no. 1, pp. 59-68, 2022.
A. S. Alshrari, S. A. Hudu, S. H. Shinkafi, A. Tahir, H. Y. Raji and A. O. Jimoh. “Prevalence and transfusion risks of occult hepatitis B infection among HBcAb-positive blood donors in a high-endemic region”. Diagnostics, vol. 15, no. 4, p. 486, 2025.
G. Gemechu, W. E. Abagez, D. H. Alemayehu, A. Tesfaye, D. Tadesse, A. Kinfu, A. Mihret and A. Mulu. “Occult hepatitis B virus infection among blood donors in the capital city of Addis Ababa, Ethiopia: Implications for blood transfusion safety”. Frontiers in Gastroenterology, vol. 1, p. 887260, 2022.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Nza Hamid Al-Barznjy, Katan S. Ali
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
